Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity

@article{Wong2012Carboxylesterases1A,
  title={Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity},
  author={Chi Chun Wong and Ka-Wing Cheng and Gang Xie and Dingying Zhou and Cai-hua Zhu and Panayiotis Constantinides and Basil Rigas},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2012},
  volume={340},
  pages={422 - 432}
}
Phospho-nonsteroidal anti-inflammatory drugs (phospho-NSAIDs) are novel NSAID derivatives with improved anticancer activity and reduced side effects in preclinical models. Here, we studied the metabolism of phospho-NSAIDs by carboxylesterases and assessed the impact of carboxylesterases on the anticancer activity of phospho-NSAIDs in vitro and in vivo. The expression of human liver carboxylesterase (CES1) and intestinal carboxylesterase (CES2) in human embryonic kidney 293 cells resulted in the… 

Figures and Tables from this paper

Comparative in vitro metabolism of phospho-tyrosol-indomethacin by mice, rats and humans.
The in vitro metabolism of phospho-sulindac amide, a novel potential anticancer agent.
Pegylation Improves the Pharmacokinetics and Bioavailability of Small-Molecule Drugs Hydrolyzable by Esterases: A Study of Phospho-Ibuprofen
TLDR
Pegylation protects PI from esterase hydrolysis and improves its pharmacokinetics, and in preclinical models of colon cancer, PI-PEG is a safe and efficacious agent that merits further evaluation.
Inhibition of human carboxylesterases by ginsenosides: structure–activity relationships and inhibitory mechanism
TLDR
The structure–inhibition relationships of ginsenosides as hCES inhibitors was investigated for the first time and revealed that DM and DMG were potent inhibitors against both hC ES1A and hCes2A, while PPD and PPT were selective and strong inhibitors against hCCES2A.
The anticancer effect of phospho-tyrosol-indomethacin (MPI-621), a novel phosphoderivative of indomethacin: in vitro and in vivo studies.
We have synthesized a novel derivative of indomethacin, phospho-tyrosol-indomethacin (PTI; MPI-621), and evaluated its anticancer efficacy in vitro and in vivo. PTI inhibited the growth of human
A novel NSAID derivative, phospho-ibuprofen, prevents AOM-induced colon cancer in rats
TLDR
It is suggested that p-ibuprofen is a potential effective novel drug for long-term use in colon cancer prevention and significantly reduced the multiplicity of ACF compared with control.
Aerosol Administration of Phospho-Sulindac Inhibits Lung Tumorigenesis
TLDR
It is found that administration by inhalation delivered high levels of phospho-sulindac to the lungs and minimized its hydrolysis to less active metabolites and was highly effective in inhibiting lung tumorigenesis and significantly improved the survival of mice bearing orthotopic A549 xenografts.
...
...

References

SHOWING 1-10 OF 31 REFERENCES
The mammalian carboxylesterases: from molecules to functions.
TLDR
A comparison of the nucleotide and amino acid sequence of the mammalian carboxylesterases shows that all forms expressed in the rat can be assigned to one of three gene subfamilies with structural identities of more than 70% within each subfamily.
Phospho-Ibuprofen (MDC-917) Is a Novel Agent against Colon Cancer: Efficacy, Metabolism, and Pharmacokinetics in Mouse Models
  • G. Xie, Yu Sun, B. Rigas
  • Biology, Chemistry
    Journal of Pharmacology and Experimental Therapeutics
  • 2011
TLDR
The results provide a pharmacological basis to explain, at least in part, the anticancer efficacy and safety of this promising compound and indicate that PI merits further evaluation as an anticancer agent.
Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect.
TLDR
The results, establishing P-ASA as a potent inhibitor of the growth of several human cancer cell lines, suggest that it may possess broad anticancer properties, which merits further evaluation.
Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs
TLDR
Experimentation for an understanding of detailed substrate specificity of prodrugs for CES isozymes and its hydrolysates will help to design the ideal pro drugs.
Phospho-sulindac (OXT-328), a novel sulindac derivative, is safe and effective in colon cancer prevention in mice.
BACKGROUND & AIMS Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective cancer chemopreventive agents. However, chronic administration of NSAIDs is associated with significant side effects,
Oxidative Stress Mediates through Apoptosis the Anticancer Effect of Phospho-Nonsteroidal Anti-Inflammatory Drugs: Implications for the Role of Oxidative Stress in the Action of Anticancer Agents
TLDR
The data show that phospho-NSAIDs act against cancer through a mechanism distinct from that of various CCDs, underscore the critical role of oxidative stress in their effect, and indicate that pathways leading to oxidative stress may be useful targets for anticancer strategies.
Mammalian carboxylesterases: from drug targets to protein therapeutics.
Characterization of the Expression and Activity of Carboxylesterases 1 and 2 from the Beagle Dog, Cynomolgus Monkey, and Human
TLDR
Quantitative real-time polymerase chain reaction and Western blot analyses indicate that the pattern of CES tissue expression in monkey is similar to that of human, but the CES expression in dog is unique, with no detectable expression of CES in the intestine.
Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression.
TLDR
Carboxylesterases with the same functional subsites had a similar profile on substrate specificity and sensitivity toward phenylmethylsulfonyl fluoride and paraoxon, suggesting that these subsites play determinant roles in the recognition of substrates and inhibitors.
Phospho-sulindac (OXT-922) inhibits the growth of human colon cancer cell lines: a redox/polyamine-dependent effect.
TLDR
OXT-922 possesses promising anticancer properties and deserves further evaluation, and enhanced spermidine/spermine N(1)-acetyltransferase activity, reduced the cellular polyamine content and synergized with difluoromethylornithine to inhibit cancer cell proliferation and induce apoptosis.
...
...